The genetic basis of tuberous sclerosis

Molecular Medicine Today

Volumn 4, Issue 7, 1998, Pages 313-319

  Young, Janet ^a   Povey, Sue ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TUBERIN; UNCLASSIFIED DRUG;

CHROMOSOME 9Q; DELETION MUTANT; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; RASH; REVIEW; SEIZURE; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

GENES, TUMOR SUPPRESSOR; PEDIGREE; PROTEINS; REPRESSOR PROTEINS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031881032     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01245-3     Document Type: Review

References (48)

1. Gomez M. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann. New York Acad. Sci. 615:1991;1-7.
2. Gunther M., Penrose L. The genetics of epiloia. J. Genet. 31:1935;413-430.
3. Northrup H.et al. Variability of expression in tuberous sclerosis. J. Med. Genet. 30:1993;41-43.
4. Smalley S., Burger F., Smith M. Phenotypic variation of tuberous sclerosis in a single extended kindred. J. Med. Genet. 31:1994;761-765.
5. Sampson J.et al. Genetic aspects of tuberous sclerosis in the west of Scotland. J. Med. Genet. 26:1989;28-31.
6. Osborne J., Fryer A., Webb D. Epidemiology of tuberous sclerosis. Ann. New York Acad. Sci. 615:1991;125-127.
7. Yates J.R.W.et al. Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. Hum. Mol. Genet. 6:1997;2265-2269.
8. Povey S.et al. Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann. Hum. Genet. 58:1994;107-127.
9. European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 75:1993;1305-1315.
10. The TSC1 Consortium Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 277:1997;805-808.
11. Maheshwar M.et al. Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. Hum. Mol. Genet. 5:1996;131-137.
12. Kobayashi T.et al. Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog. Mamm. Genome. 8:1997;554-558.
13. Kobayashi T.et al. cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. Nucleic Acids Res. 23:1995;2608-2613.
14. Kim K.et al. Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product. Cell. Mol. Biol. Res. 41:1995;515-526.
15. Olsson P.et al. Expression and differential splicing of the mouse TSC2 homologue. Mamm. Genome. 7:1996;212-215.
16. Harris P.C.et al. Autosomal dominant polycystic kidney disease: molecular analysis. Hum. Mol. Genet. 4:1995;1745-1749.
17. Michalet X.et al. Dynamic molecular combing: stretching the whole human genome for high resolution studies. Science. 277:1997;1518-1523.
18. Brook-Carter P.et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nat. Genet. 8:1994;328-332.
19. Sampson J.et al. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am. J. Hum. Genet. 61:1997;843-851.
20. Verhoef S.et al. Somatic mosaicism and clinical variation in tuberous sclerosis complex. Lancet. 345:1995;202.
21. Wilson P.et al. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum. Mol. Genet. 5:1996;249-256.
22. van Bakel I.et al. Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT). Hum. Mol. Genet. 6:1997;1409-1414.
23. Jones A.C.et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum. Mol. Genet. 6:1997;2155-2161.
24. Maheshwar M.et al. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for mis-sense mutations in tuberous sclerosis. Hum. Mol. Genet. 6:1997;1991-1996.
25. Au K-S.et al. Germline mutational analysis of the TSC2 gene in 90 tuberous sclerosis patients. Am. J. Hum. Genet. 62:1998;286-294.
26. Jobert S.et al. Deletion of 11 amino acids in tuberin associated with severe tuberous sclerosis phenotypes: evidence for a new essential domain in the first third of the protein. Eur. J. Hum. Genet. 5:1997;280-287.
27. Eker R., Mossige J. A dominant gene for renal adenomas in the rat. Nature. 189:1961;858-859.
28. Kobayashi T.et al. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat. Genet. 9:1995;70-74.
29. Yeung R.et al. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11413-11416.
30. Yeung R.S., Katsetos C.D., Klein-Szanto A. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am. J. Pathol. 151:1997;1477-1486.
31. Kobayashi T.et al. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc. Natl. Acad. Sci. U. S. A. 94:1997;3990-3993.
32. Jin F.et al. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9154-9159.
33. Wienecke R., Konig A., DeClue J. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 270:1995;16409-16414.
34. Wienecke R.et al. Co-localisation of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene. 13:1996;913-923.
35. Xiao G-H.et al. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J. Biol. Chem. 272:1997;6097-6100.
36. Soucek T.et al. Role of the tuberous sclerosis gene-2 product in cell cycle control. J. Biol. Chem. 272:1997;29301-29308.
37. Green A., Smith M., Yates J. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat. Genet. 6:1994;193-196.
38. Green A., Johnson P., Yates J. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum. Mol. Genet. 3:1994;1833-1834.
39. Carbonara C.et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum. Mol. Genet. 3:1994;1829-1832.
40. Cavenee W.K.et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305:1983;779-784.
41. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U. S. A. 68:1971;820-823.
42. Henske E.P.et al. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumours. Am. J. Pathol. 151:1997;1639-1647.
43. Sepp T., Yates J., Green A. Loss of heterozygosity in tuberous sclerosis hamartomas. J. Med. Genet. 33:1996;962-964.
44. Henske E.et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am. J. Hum. Genet. 59:1996;400-406.
45. Henske E.et al. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer. 13:1995;295-298.
46. Green A., Sepp T., Yates J. Clonality of tuberous sclerosis hamartomas shown by non-random X-chromosome inactivation. Hum. Genet. 97:1996;240-243.
47. Carbonara C.et al. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer. 15:1996;18-25.
48. Webb D., Osborne J. Non-penetrance in tuberous sclerosis. J. Med. Genet. 28:1991;417-419.